Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study
机构:[1]Key Laboratory of Carcinogenesis andTranslational Research (Ministry ofEducation/Beijing), Breast Center, PekingUniversity Cancer Hospital & Institute,Beijing, People’s Republic of China[2]Department of Biostatistics, PekingUniversity First Hospital, Beijing, People’sRepublic of China[3]Department of BreastCenter, Peking University People’s Hospital,Beijing, People’s Republic of China[4]TheFourth Hospital of Hebei Medical University,Shijiazhuang, People’s Republic of China河北医科大学第四医院[5]Shunyi District Health Care Hospital forWomen and Children of Beijing, Beijing,People’s Republic of China[6]HaidianMaternal and Child Health Hospital, Beijing,People’s Republic of China[7]PekingUniversity Clinical Research Institute, PekingUniversity Health Science Center, Beijing,People’s Republic of China
Purpose: This study aimed to establish and evaluate the usefulness of a simple, practical, and easy-to-promote machine learning model based on ultrasound imaging features for diagnosing breast cancer (BC). Materials and Methods: Logistic regression, random forest, extra trees, support vector, multilayer perceptron, and XG Boost models were developed. The modeling data set of 1345 cases was from a tertiary class A hospital in China. The external validation data set of 1965 cases were from 3 tertiary class A hospitals and 2 primary hospitals. The area under the receiver operating characteristic curve (AUC) was used as the main evaluation index, and pathological biopsy was used as the gold standard for evaluating each model. Diagnostic capability was also compared with that of clinicians. Results: Among the six models, the logistic model showed superior diagnostic efficiency, with an AUC of 0.771 and 0.906 and Brier scores of 0.181 and 0.165 in the test and validation sets, respectively. The AUCs of the clinician diagnosis and the logistic model were 0.913 and 0.906. Their AUCs in the tertiary class A hospitals were 0.915 and 0.915, respectively, and were 0.894 and 0.873 in primary hospitals, respectively. Conclusion: The externally validated logical model can be used to distinguish between malignant and benign breast lesions in ultrasound images. Compared with clinician diagnosis, the logistic model has better diagnostic efficiency, making it potentially useful to assist in screening, particularly in lower level medical institutions.
基金:
Beijing Municipal Science
and Technology Project (NO: D161100000816006).
第一作者机构:[1]Key Laboratory of Carcinogenesis andTranslational Research (Ministry ofEducation/Beijing), Breast Center, PekingUniversity Cancer Hospital & Institute,Beijing, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[1]Key Laboratory of Carcinogenesis andTranslational Research (Ministry ofEducation/Beijing), Breast Center, PekingUniversity Cancer Hospital & Institute,Beijing, People’s Republic of China[2]Department of Biostatistics, PekingUniversity First Hospital, Beijing, People’sRepublic of China[7]PekingUniversity Clinical Research Institute, PekingUniversity Health Science Center, Beijing,People’s Republic of China[*1]Peking University First Hospital, Xicheng District, Beijing, 100034, People’s Republic of China[*2]Peking University Cancer Hospital & Institute, Haidian District, Beijing, 100142, People’s Republic of China
推荐引用方式(GB/T 7714):
Huo Ling,Tan Yao,Wang Shu,et al.Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study[J].CANCER MANAGEMENT AND RESEARCH.2021,13:3367-3379.doi:10.2147/CMAR.S297794.
APA:
Huo, Ling,Tan, Yao,Wang, Shu,Geng, Cuizhi,Li, Yi...&Ouyang, Tao.(2021).Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study.CANCER MANAGEMENT AND RESEARCH,13,
MLA:
Huo, Ling,et al."Machine Learning Models to Improve the Differentiation Between Benign and Malignant Breast Lesions on Ultrasound: A Multicenter External Validation Study".CANCER MANAGEMENT AND RESEARCH 13.(2021):3367-3379